SE325276B - - Google Patents

Info

Publication number
SE325276B
SE325276B SE08101/66A SE810166A SE325276B SE 325276 B SE325276 B SE 325276B SE 08101/66 A SE08101/66 A SE 08101/66A SE 810166 A SE810166 A SE 810166A SE 325276 B SE325276 B SE 325276B
Authority
SE
Sweden
Application number
SE08101/66A
Inventor
K Bentley
B Meek
J Tattersall
Original Assignee
Reckitt & Sons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt & Sons Ltd filed Critical Reckitt & Sons Ltd
Publication of SE325276B publication Critical patent/SE325276B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/09Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
    • C07D489/10Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
    • C07D489/12Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE08101/66A 1965-06-15 1966-06-14 SE325276B (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB25289/65A GB1136214A (en) 1965-06-15 1965-06-15 Thebaine and oripavine derivatives

Publications (1)

Publication Number Publication Date
SE325276B true SE325276B (xx) 1970-06-29

Family

ID=10225305

Family Applications (1)

Application Number Title Priority Date Filing Date
SE08101/66A SE325276B (xx) 1965-06-15 1966-06-14

Country Status (14)

Country Link
AT (1) AT272530B (xx)
BE (1) BE682551A (xx)
BR (1) BR6680359D0 (xx)
CH (1) CH558362A (xx)
DE (1) DE1620206A1 (xx)
DK (1) DK115926B (xx)
ES (1) ES327925A1 (xx)
FI (1) FI49724C (xx)
FR (1) FR6395M (xx)
GB (1) GB1136214A (xx)
LU (1) LU51306A1 (xx)
NL (1) NL6608255A (xx)
NO (1) NO119590B (xx)
SE (1) SE325276B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2554816B1 (fr) * 1983-11-16 1986-09-26 Sanofi Sa Nouveau derive de la nororipavine presentant a la fois une activite agoniste et antagoniste des recepteurs morphiniques
KR100204659B1 (ko) * 1996-05-28 1999-06-15 강재헌 신규한 부프레노핀계 진통제용 화합물
AUPQ968300A0 (en) 2000-08-25 2000-09-21 Glaxo Wellcome Australia Ltd Chemical methods
GB2388369B (en) * 2002-05-10 2004-05-05 Reckitt Benckiser Healthcare Demethylation of thebaine derivative
GB0421687D0 (en) 2004-09-30 2004-11-03 Johnson Matthey Plc Preparation of opiate analgesics
WO2006091885A2 (en) 2005-02-24 2006-08-31 Dr Pharma Nova, Llc A registry method and control system for dea schedule ii-v medicines
DE102006054731B4 (de) 2006-11-21 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
WO2010014229A1 (en) * 2008-07-30 2010-02-04 Purdue Pharma L.P. Buprenorphine analogs
CA2738758C (en) * 2008-09-30 2016-11-29 Mallinckrodt Inc. Processes for the alkylation of norbuprenorphine with reduced impurity formation
CN102459275A (zh) 2009-04-24 2012-05-16 布鲁克大学 制备吗啡烷和吗啡酮化合物的方法
GB201111775D0 (en) 2011-07-08 2011-08-24 Univ Bath Compounds and uses thereof
CN107669662A (zh) 2011-12-12 2018-02-09 Lts勒曼治疗系统股份公司 包含丁丙诺啡的经皮递送系统
EP3791861A1 (en) 2012-07-26 2021-03-17 Camurus AB Opioid formulations
JP6317755B2 (ja) * 2012-12-07 2018-04-25 パーデュー、ファーマ、リミテッド、パートナーシップ オピオイド受容体モジュレーターとしてのブプレノルフィン類似体
CA2914425C (en) 2013-06-04 2019-09-17 Lts Lohmann Therapie-Systeme Ag Transdermal delivery system
CA3238849A1 (en) 2021-12-16 2023-06-22 Arevipharma Gmbh Method of making buprenorphine and precursor compounds thereof

Also Published As

Publication number Publication date
FI49724C (fi) 1975-09-10
CH558362A (de) 1975-01-31
FR6395M (xx) 1968-10-21
ES327925A1 (es) 1967-04-01
GB1136214A (en) 1968-12-11
NO119590B (xx) 1970-06-08
BE682551A (xx) 1966-11-14
NL6608255A (xx) 1966-12-16
BR6680359D0 (pt) 1973-12-26
LU51306A1 (xx) 1966-08-16
DE1620206A1 (de) 1970-03-19
FI49724B (xx) 1975-06-02
DK115926B (da) 1969-11-24
AT272530B (de) 1969-07-10

Similar Documents

Publication Publication Date Title
FR6395M (xx)
DK136111C (xx)
JPS45472Y1 (xx)
JPS437741Y1 (xx)
JPS4511914Y1 (xx)
JPS437939Y1 (xx)
JPS4325688Y1 (xx)
BE675557A (xx)
BE675544A (xx)
BE673504A (xx)
BE673347A (xx)
BE673044A (xx)
BE685406A (xx)
BE672918A (xx)
NL6504001A (xx)
NL6502585A (xx)
BE675014A (xx)
BE673778A (xx)
BE675553A (xx)
BE685796A (xx)
BE675840A (xx)
BE675558A (xx)
BE674966A (xx)
BE671963A (xx)
BE671318A (xx)